American Equity Reports Fourth Quarter and Full Year 2021 Results
American Equity Investment Life Holding Company (AEL) announced strong fourth quarter 2021 results with net income of $82.2 million, or $0.88 per diluted share, contributing to a total full year income of $430.3 million. Non-GAAP operating income for Q4 was $75.8 million, while full year non-GAAP income reached $290.5 million. The company accelerated private asset deployment with $2.3 billion sourced in Q4, aiming for a 30-40% asset allocation in the future. Book value per share stood at $60.78, reflecting solid positioning for growth in reinsurance and investments.
- Fourth quarter 2021 net income of $82.2 million; full year 2021 net income of $430.3 million.
- Non-GAAP operating income for Q4 of $75.8 million, up from $71.7 million in Q4 2020.
- Accelerated private asset deployment of $2.3 billion in Q4, totaling $3.4 billion for 2021.
- Formation of AEL Bermuda Reinsurance Company with $4 billion in-force policies and $300 million capital.
- Increased FIA sales by 48% year-over-year, signaling strong product performance.
- Non-GAAP operating income negatively impacted by $21.2 million due to actuarial assumption revisions in Q4.
- Total sales decreased 43% compared to Q4 2020, despite a significant shift to FIAs.
Company Highlights
-
Fourth quarter 2021 net income available to common stockholders of
, or$82.2 million per diluted common share; full year 2021 net income available to common stockholders of$0.88 , or$430.3 million per diluted common share$4.55
-
Non-GAAP operating income1 available to common stockholders for the fourth quarter and full year 2021 was
, or$75.8 million per diluted common share, and$0.81 , or$290.5 million per diluted common share, respectively; fourth quarter 2021 and full year 2021 non-GAAP operating income available to common stockholders, excluding notable items1, of$3.07 , or$97.1 million per diluted common share, and$1.04 , or$368.5 million per diluted common share, respectively$3.90
-
Accelerated private asset deployment with
sourced in the quarter bringing full year total to$2.3 billion ; private assets at approximately$3.4 billion 15% of total invested assets atDecember 31, 2021 , as part of plans to ramp to 30-40% asset allocation over time
-
Formation and licensing of
AEL Bermuda Reinsurance Company and transfer of of in-force policies supported by approximately$4 billion of capital on a$300 million Bermuda regulatory basis lays the foundation for future growth in reinsurance side car vehicles to drive "fee-like" return on assets (ROA) earnings
-
Executed issuance of Tranche 2 shares thereby cementing cornerstone partnership with Brookfield Reinsurance with all necessary approvals; year-end notional value under reinsurance agreements of
generating six to seven years of "fee-like" ROA earnings$4.1 billion
-
Book value per common share of
at$60.78 December 31, 2021 ; non-GAAP book value per common share excluding accumulated other comprehensive income (AOCI)1 of at$40.80 December 31, 2021 ; excluding both AOCI and net impact of accounting for fair value of derivatives and embedded derivatives, non-GAAP book value per common share1 of at$37.83 December 31, 2021
American Equity's President and CEO,
Non-GAAP operating income1 available to common stockholders excluding notables for the fourth quarter was
Actuarial assumption revisions utilized in the determination of deferred policy acquisition costs, deferred sales inducements, and the liability for future policy benefits to be paid for lifetime income benefit riders (LIBR) negatively affected non-GAAP operating income1 by
The year-over-year increase in quarterly non-GAAP operating income1 available to common stockholders excluding the impact of actuarial assumption revisions in the fourth quarter of 2021 primarily reflected decreases in interest credited to account balances and the change in LIBR liability offset partly by an increase in other operating costs and expenses.
Compared to the fourth quarter of 2020, the change in the liability for future benefits to be paid for LIBR declined by
Compared to the fourth quarter of 2020, amortization of deferred policy acquisition and sales inducement costs increased by
CONTINUED DEPLOYMENT INTO PRIVATE ASSETS AS PART OF RAMPING TO
American Equity’s investment spread was
Average yield on invested assets was
The aggregate cost of money for annuity liabilities of
FUNDS UNDER MANAGEMENT INCREASE
Policyholder funds under management at
CAUTION REGARDING FORWARD-LOOKING STATEMENTS
The forward-looking statements in this release, such as expect, intend, should, strategy, or similar words, as well as specific projections of future results, are based on assumptions and expectations that involve risks and uncertainties, including the "Risk Factors" the company describes in its
CONFERENCE CALL
American Equity will hold a conference call to discuss fourth quarter 2021 earnings on
The call may also be accessed by telephone at 855-865-0606, passcode 9660967 (international callers, please dial 704-859-4382). An audio replay will be available shortly after the call on American Equity's website. An audio replay will also be available via telephone through
ABOUT AMERICAN EQUITY
At
- Use of non-GAAP financial measures, including those that isolate notable items, is discussed in this release in the tables that follow the text of the release.
-
Pertinent notable items consist of
impact related to actuarial assumption updates made in Q4 2021,$21,235 impact related to actuarial assumption updates made in Q3 2021,$56,801 impact related to actuarial assumption updates made in Q3 2020, and$340,895 tax benefit related to the CARES Act in Q1 2020. The presentation of notable items is intended to help investors better understand our results and to evaluate and forecast those results. For more information, see page 6 of our$30,778 December 31, 2021 financial supplement. -
Non-trendable items are the impact of investment yield – additional prepayment income and cost of money effect of over (under) hedging as shown in our
December 31, 2021 financial supplement on page 10, “Spread Results”. - For the purposes of this document, all references to sales are on a gross basis. Gross sales is defined as sales before the use of reinsurance.
Unaudited (Dollars in thousands, except per share data)
Consolidated Statements of Operations
|
Three Months Ended
|
|
Year Ended
|
||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
Revenues: |
|
|
|
|
|
|
|
||||||||
Premiums and other considerations |
$ |
14,553 |
|
|
$ |
10,279 |
|
|
$ |
58,202 |
|
|
$ |
39,382 |
|
Annuity product charges |
|
60,310 |
|
|
|
65,963 |
|
|
|
242,631 |
|
|
|
251,227 |
|
Net investment income |
|
514,599 |
|
|
|
521,725 |
|
|
|
2,037,475 |
|
|
|
2,182,078 |
|
Change in fair value of derivatives |
|
522,251 |
|
|
|
443,867 |
|
|
|
1,348,735 |
|
|
|
34,666 |
|
Net realized losses on investments |
|
(10,478 |
) |
|
|
(12,135 |
) |
|
|
(13,242 |
) |
|
|
(80,680 |
) |
Other revenue |
|
8,026 |
|
|
|
— |
|
|
|
15,670 |
|
|
|
— |
|
Loss on extinguishment of debt |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(2,024 |
) |
Total revenues |
|
1,109,261 |
|
|
|
1,029,699 |
|
|
|
3,689,471 |
|
|
|
2,424,649 |
|
|
|
|
|
|
|
|
|
||||||||
Benefits and expenses: |
|
|
|
|
|
|
|
||||||||
Insurance policy benefits and change in future policy benefits |
|
16,975 |
|
|
|
13,066 |
|
|
|
67,983 |
|
|
|
49,742 |
|
Interest sensitive and index product benefits |
|
574,816 |
|
|
|
325,912 |
|
|
|
2,681,406 |
|
|
|
1,543,270 |
|
Amortization of deferred sales inducements |
|
59,409 |
|
|
|
22,768 |
|
|
|
152,692 |
|
|
|
438,164 |
|
Change in fair value of embedded derivatives |
|
186,802 |
|
|
|
568,836 |
|
|
|
(358,302 |
) |
|
|
(1,286,787 |
) |
Interest expense on notes payable |
|
6,259 |
|
|
|
6,391 |
|
|
|
25,581 |
|
|
|
25,552 |
|
Interest expense on subordinated debentures |
|
1,330 |
|
|
|
1,325 |
|
|
|
5,324 |
|
|
|
5,557 |
|
Amortization of deferred policy acquisition costs |
|
82,999 |
|
|
|
26,145 |
|
|
|
268,328 |
|
|
|
649,554 |
|
Other operating costs and expenses |
|
66,279 |
|
|
|
55,321 |
|
|
|
243,712 |
|
|
|
183,636 |
|
Total benefits and expenses |
|
994,869 |
|
|
|
1,019,764 |
|
|
|
3,086,724 |
|
|
|
1,608,688 |
|
Income before income taxes |
|
114,392 |
|
|
|
9,935 |
|
|
|
602,747 |
|
|
|
815,961 |
|
Income tax expense |
|
21,255 |
|
|
|
1,193 |
|
|
|
128,755 |
|
|
|
144,501 |
|
Net income |
|
93,137 |
|
|
|
8,742 |
|
|
|
473,992 |
|
|
|
671,460 |
|
Less: Preferred stock dividends |
|
10,919 |
|
|
|
15,004 |
|
|
|
43,675 |
|
|
|
33,515 |
|
Net income (loss) available to common stockholders |
$ |
82,218 |
|
|
$ |
(6,262 |
) |
|
$ |
430,317 |
|
|
$ |
637,945 |
|
|
|
|
|
|
|
|
|
||||||||
Earnings (loss) per common share |
$ |
0.89 |
|
|
$ |
(0.07 |
) |
|
$ |
4.58 |
|
|
$ |
6.93 |
|
Earnings (loss) per common share - assuming dilution |
$ |
0.88 |
|
|
$ |
(0.07 |
) |
|
$ |
4.55 |
|
|
$ |
6.90 |
|
|
|
|
|
|
|
|
|
||||||||
Weighted average common shares outstanding (in thousands): |
|
|
|
|
|
|
|
||||||||
Earnings (loss) per common share |
|
92,479 |
|
|
|
92,904 |
|
|
|
93,860 |
|
|
|
92,055 |
|
Earnings (loss) per common share - assuming dilution |
|
93,378 |
|
|
|
93,352 |
|
|
|
94,491 |
|
|
|
92,392 |
|
Unaudited (Dollars in thousands, except per share data)
NON-GAAP FINANCIAL MEASURES
In addition to net income (loss) available to common stockholders, we have consistently utilized non-GAAP operating income available to common stockholders and non-GAAP operating income available to common stockholders per common share - assuming dilution, non-GAAP financial measures commonly used in the life insurance industry, as economic measures to evaluate our financial performance. Non-GAAP operating income available to common stockholders equals net income (loss) available to common stockholders adjusted to eliminate the impact of items that fluctuate from quarter to quarter in a manner unrelated to core operations, and we believe measures excluding their impact are useful in analyzing operating trends. The most significant adjustments to arrive at non-GAAP operating income available to common stockholders eliminate the impact of fair value accounting for our fixed index annuity business. These adjustments are not economic in nature but rather impact the timing of reported results. We believe the combined presentation and evaluation of non-GAAP operating income available to common stockholders together with net income (loss) available to common stockholders provides information that may enhance an investor’s understanding of our underlying results and profitability.
Reconciliation from Net Income (Loss) Available to Common Stockholders to Non-GAAP Operating Income Available to Common Stockholders and Non-GAAP Operating Income Available to Common Stockholders, Excluding Notable Items
|
Three Months Ended
|
|
Year Ended
|
||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
Net income (loss) available to common stockholders |
$ |
82,218 |
|
|
$ |
(6,262 |
) |
|
$ |
430,317 |
|
|
$ |
637,945 |
|
Adjustments to arrive at non-GAAP operating income available to common stockholders: (a) |
|
|
|
|
|
|
|
||||||||
Net realized losses on financial assets, including credit losses |
|
7,771 |
|
|
|
9,369 |
|
|
|
10,299 |
|
|
|
59,355 |
|
Change in fair value of derivatives and embedded derivatives |
|
(14,544 |
) |
|
|
90,616 |
|
|
|
(187,290 |
) |
|
|
(784,005 |
) |
Income taxes |
|
383 |
|
|
|
(21,996 |
) |
|
|
37,184 |
|
|
|
155,808 |
|
Non-GAAP operating income available to common stockholders |
|
75,828 |
|
|
|
71,727 |
|
|
|
290,510 |
|
|
|
69,103 |
|
Impact of notable items (b) |
|
21,235 |
|
|
|
— |
|
|
|
78,036 |
|
|
|
310,117 |
|
Non-GAAP operating income available to common stockholders, excluding notable items |
$ |
97,063 |
|
|
$ |
71,727 |
|
|
$ |
368,546 |
|
|
$ |
379,220 |
|
|
|
|
|
|
|
|
|
||||||||
Per common share - assuming dilution: |
|
|
|
|
|
|
|
||||||||
Net income (loss) available to common stockholders |
$ |
0.88 |
|
|
$ |
(0.07 |
) |
|
$ |
4.55 |
|
|
$ |
6.90 |
|
Adjustments to arrive at non-GAAP operating income available to common stockholders: |
|
|
|
|
|
|
|
||||||||
Net realized losses on financial assets, including credit losses |
|
0.08 |
|
|
|
0.10 |
|
|
|
0.11 |
|
|
|
0.64 |
|
Change in fair value of derivatives and embedded derivatives |
|
(0.15 |
) |
|
|
0.97 |
|
|
|
(1.98 |
) |
|
|
(8.48 |
) |
Income taxes |
|
— |
|
|
|
(0.23 |
) |
|
|
0.39 |
|
|
|
1.69 |
|
Non-GAAP operating income available to common stockholders |
|
0.81 |
|
|
|
0.77 |
|
|
|
3.07 |
|
|
|
0.75 |
|
Impact of notable items |
|
0.23 |
|
|
|
— |
|
|
|
0.83 |
|
|
|
3.36 |
|
Non-GAAP operating income available to common stockholders, excluding notable items |
$ |
1.04 |
|
|
$ |
0.77 |
|
|
$ |
3.90 |
|
|
$ |
4.11 |
|
Notable Items
|
Three Months Ended
|
|
Year Ended
|
|||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|||||
Notable items impacting non-GAAP operating income available to common stockholders: |
|
|
|
|
|
|
|
|||||
Impact of actuarial assumption updates |
$ |
21,235 |
|
$ |
— |
|
$ |
78,036 |
|
$ |
340,895 |
|
Tax benefit related to the CARES Act |
|
— |
|
|
— |
|
|
— |
|
|
(30,778 |
) |
Total notable items (b) |
$ |
21,235 |
|
$ |
— |
|
$ |
78,036 |
|
$ |
310,117 |
|
(a) |
|
Adjustments to net income (loss) available to common stockholders to arrive at non-GAAP operating income available to common stockholders are presented net of related adjustments to amortization of deferred sales inducements and deferred policy acquisition costs and accretion of lifetime income benefit rider (LIBR) reserves where applicable. |
(b) |
|
Notable items reflect the after-tax impact to non-GAAP operating income available to common stockholders for certain items that do not reflect the company's expected ongoing operations. Notable items primarily include the impact from actuarial assumption updates. The presentation of notable items is intended to help investors better understand our results and to evaluate and forecast those results. |
Unaudited (Dollars in thousands, except share and per share data)
Book Value per Common Share
|
Q4 2021 |
||
Total stockholders’ equity |
$ |
6,323,127 |
|
Equity available to preferred stockholders (a) |
|
(700,000 |
) |
Total common stockholders' equity (b) |
|
5,623,127 |
|
Accumulated other comprehensive income |
|
(1,848,789 |
) |
Total common stockholders’ equity excluding AOCI (b) |
|
3,774,338 |
|
Net impact of fair value accounting for derivatives and embedded derivatives |
|
(274,981 |
) |
Total common stockholders’ equity excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives (b) |
$ |
3,499,357 |
|
|
|
||
Common shares outstanding |
|
92,513,517 |
|
|
|
||
Book Value per Common Share: (c) |
|
||
Book value per common share |
$ |
60.78 |
|
Book value per common share excluding AOCI (b) |
$ |
40.80 |
|
Book value per common share excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives (b) |
$ |
37.83 |
|
(a) |
|
Equity available to preferred stockholders is equal to the redemption value of outstanding preferred stock plus share dividends declared but not yet issued. |
(b) |
|
Total common stockholders' equity, total common stockholders' equity excluding AOCI and total common stockholders' equity excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives, non-GAAP financial measures, exclude equity available to preferred stockholders. Total common stockholders’ equity and book value per common share excluding AOCI, non-GAAP financial measures, are based on common stockholders’ equity excluding the effect of AOCI. Since AOCI fluctuates from quarter to quarter due to unrealized changes in the fair value of available for sale securities, we believe these non-GAAP financial measures provide useful supplemental information. Total common stockholders' equity and book value per common share excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives, non-GAAP financial measures, are based on common stockholders' equity excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives. Since the net impact of fair value accounting for our derivatives and embedded derivatives fluctuates from quarter to quarter and the most significant impacts relate to fair value accounting for our fixed index annuity business and are not economic in nature but rather impact the timing of reported results, we believe these non-GAAP financial measures provide useful supplemental information. |
(c) |
|
Book value per common share including and excluding AOCI and book value per common share excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives are calculated as total common stockholders’ equity, total common stockholders’ equity excluding AOCI and total common stockholders' equity excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives divided by the total number of shares of common stock outstanding.
|
Unaudited (Dollars in thousands)
NON-GAAP FINANCIAL MEASURES
Average Common Stockholders' Equity and Return on Average Common Stockholders' Equity
Return on average common stockholders' equity measures how efficiently we generate profits from the resources provided by our net assets. Return on average common stockholders' equity is calculated by dividing net income available to common stockholders, for the trailing twelve months, by average equity available to common stockholders. Non-GAAP operating return on average common stockholders' equity excluding average accumulated other comprehensive income (AOCI) is calculated by dividing non-GAAP operating income available to common stockholders, for the trailing twelve months, by average common stockholders' equity excluding average AOCI. We exclude AOCI because AOCI fluctuates from quarter to quarter due to unrealized changes in the fair value of available for sale investments.
|
Twelve Months Ended |
||
|
|
||
Average Common Stockholders' Equity Excluding Average AOCI |
|
||
Average total stockholders' equity |
$ |
6,336,058 |
|
Average equity available to preferred stockholders |
|
(700,000 |
) |
Average equity available to common stockholders |
|
5,636,058 |
|
Average AOCI |
|
(2,026,173 |
) |
Average common stockholders' equity excluding average AOCI |
|
3,609,885 |
|
Impact of notable items on average common stockholders' equity excluding average AOCI |
|
39,018 |
|
Average common stockholders' equity excluding average AOCI and notables |
$ |
3,648,903 |
|
|
|
||
Net income available to common stockholders |
$ |
430,317 |
|
Adjustments to arrive at non-GAAP operating income available to common stockholders: (a) |
|
||
Net realized losses on financial assets, including credit losses |
|
10,299 |
|
Change in fair value of derivatives and embedded derivatives |
|
(187,290 |
) |
Income taxes |
|
37,184 |
|
Non-GAAP operating income available to common stockholders |
|
290,510 |
|
Impact of notable items (b) |
|
78,036 |
|
Non-GAAP operating income available to common stockholders, excluding notable items |
$ |
368,546 |
|
|
|
||
Return on Average Common Stockholders' Equity |
|
||
Net income available to common stockholders |
|
7.6 |
% |
|
|
||
Return on Average Common Stockholders' Equity Excluding Average AOCI |
|
||
Non-GAAP operating income available to common stockholders |
|
8.0 |
% |
Non-GAAP operating income available to common stockholders, excluding notable items |
|
10.1 |
% |
Notable Items
|
Twelve Months Ended |
|
|
|
|
Notable items impacting Non-GAAP operating income available to common stockholders: |
|
|
Impact of actuarial assumption updates |
$ |
78,036 |
Total notable items (b) |
$ |
78,036 |
(a) |
|
Adjustments to net income available to common stockholders to arrive at non-GAAP operating income available to common stockholders are presented net of related adjustments to amortization of deferred sales inducements (DSI) and deferred policy acquisition costs (DAC) and accretion of lifetime income benefit rider (LIBR) reserves where applicable. |
(b) |
|
Notable items reflect the after-tax impact to non-GAAP operating income available to common stockholders for certain items that do not reflect the company's expected ongoing operations. Notable items primarily include the impact from actuarial assumption updates. The presentation of notable items is intended to help investors better understand our results and to evaluate and forecast those results. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220217005903/en/
(515) 273-3763, sschwartz@american-equity.com
Source:
FAQ
What were American Equity Investment Life Holding's fourth quarter 2021 earnings?
What was the full year 2021 net income for AEL?
How much did AEL source in private assets during the fourth quarter of 2021?
What is the status of American Equity's book value per share as of December 31, 2021?